David T. Karzon

6.0k total citations · 2 hit papers
125 papers, 4.5k citations indexed

About

David T. Karzon is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, David T. Karzon has authored 125 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Epidemiology, 39 papers in Infectious Diseases and 26 papers in Immunology. Recurrent topics in David T. Karzon's work include Respiratory viral infections research (43 papers), Influenza Virus Research Studies (26 papers) and Virology and Viral Diseases (25 papers). David T. Karzon is often cited by papers focused on Respiratory viral infections research (43 papers), Influenza Virus Research Studies (26 papers) and Virology and Viral Diseases (25 papers). David T. Karzon collaborates with scholars based in United States. David T. Karzon's co-authors include Peter F. Wright, Pearay L. Ogra, Barney S. Graham, Juliette Thompson, H. F. Clark, Sarah H. Sell, Mark D. Perkins, Margaret MacGillivray, Almen L. Barron and Paul Wright and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Clinical Investigation.

In The Last Decade

David T. Karzon

121 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice.

1991 426 citations Barney S. Graham, Peter F. Wright et al. Journal of Clinical Investigation profile →
Immunoglobulin Response in Serum and Secretions after Immunization with Live and Inactivated Poliovaccine and Natural Infection

1968 310 citations Pearay L. Ogra, David T. Karzon et al. profile →

Peers

Countries citing papers authored by David T. Karzon

Since Specialization

Citations

This map shows the geographic impact of David T. Karzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David T. Karzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David T. Karzon more than expected).

Fields of papers citing papers by David T. Karzon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David T. Karzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David T. Karzon. The network helps show where David T. Karzon may publish in the future.

Co-authorship network of co-authors of David T. Karzon

This figure shows the co-authorship network connecting the top 25 collaborators of David T. Karzon. A scholar is included among the top collaborators of David T. Karzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David T. Karzon. David T. Karzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Control of Acute Lower Respiratory Illness in the Developing World: An Assessment of Vaccine Intervention 1991 ·Clinical Infectious Diseases ·David T. Karzon	5
2	Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. breakdown → 1991 ·Journal of Clinical Investigation ·Barney S. Graham, (unknown), Peter F. Wright, David T. Karzon	426
3	The future roles of oral polio vaccine and enhanced potency inactivated polio vaccine 1991 ·PubMed ·David T. Karzon	3
4	Natural History of Pertussis Antibody in the Infant and Effect on Vaccine Response 1990 ·The Journal of Infectious Diseases ·(unknown), Michael D. Decker, Kathryn M. Edwards, Sarah H. Sell, David T. Karzon	167
5	The Search for an Improved Pertussis Vaccine 1990 ·Pediatric Annals ·Kathryn M. Edwards, David T. Karzon	1
6	Development of an AIDS Vaccine 1990 ·Infectious Disease Clinics of North America ·Barney S. Graham, David T. Karzon	5
7	Candidate Rotavirus Vaccine (Rhesus Rotavirus Strain) in Children: An Evaluation 1987 ·PEDIATRICS ·Paul Wright, Takeshi Tajima, Jon S. Thompson, (unknown), Albert Z. Kapikian, David T. Karzon	35
8	Cytotoxic T-cell response to respiratory syncytial virus in mice 1985 ·Journal of Virology ·Charles R. M. Bangham, Martin J. Cannon, David T. Karzon, B A Askonas	92
9	Transposition of the great arteries: Possible risk factorfor Haemophilus influenzae type b meningitis 1979 ·The Journal of Pediatrics ·Sandra G. Hassink, Robert J. Boucek, T.P. Graham, David T. Karzon, Sarah H. Sell	3
10	Mediastinal pancreatic pseudocyst in infancy 1977 ·The Journal of Pediatrics ·R. E. Mallard, (unknown), James A. O’Neill, David T. Karzon	8
11	Swine-like influenza vaccine: A commentary 1976 ·The Journal of Pediatrics ·Floyd W. Denny, W. Paul Glezen, David T. Karzon, Sol Katz, S Krugman, Kenneth McIntosh, Robert H. Parrott	2
12	Clinical reactions and serologic response following inactivated monovalent influenza type B vaccine in young children and infants 1976 ·The Journal of Pediatrics ·Peter F. Wright, Sarah H. Sell, Juliette Thompson, David T. Karzon	40
13	Safety and antigenicity of influenza A/Hong Kong/68-ts-1 [E] (H3N2) vaccine in young seronegative children 1975 ·The Journal of Pediatrics ·Peter F. Wright, Sarah H. Sell, T Shinozaki, Juliette Thompson, David T. Karzon	36
14	Smallpox vaccination in the United States: The end of an era 1972 ·The Journal of Pediatrics ·David T. Karzon	6
15	Cytogenetic effects of measles virus fusion factor (FF) on human leukocytes 1971 ·Cytogenetic and Genome Research ·(unknown), Maimon M. Cohen, David T. Karzon	4
16	Poliovirus antibody response in patients withacute leukemia 1971 ·The Journal of Pediatrics ·Pearay L. Ogra, Lucius F. Sinks, David T. Karzon	29
17	Density Separable Fractions during Growth of Measles Virus 1966 ·The Journal of Immunology ·Yoshio Numazaki, David T. Karzon	10
18	Soluble Antigen of Measles Virus 1966 ·The Journal of Immunology ·Yoshio Numazaki, David T. Karzon	9
19	Hemagglutination and Hemagglutination-Inhibition Studies with Echo Viruses 1962 ·The Journal of Immunology ·Robert H. Bussell, David T. Karzon, (unknown)	12
20	THE PATHOGENESIS OF INFECTION WITH A VIRULENT (CG 179) AND AN AVIRULENT (B) STRAIN OF NEWCASTLE DISEASE VIRUS IN THE CHICKEN 1951 ·The Journal of Experimental Medicine ·David T. Karzon, Frederik B. Bang	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact